Navigation Links
Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting
Date:12/2/2009

new blood vessels that feed tumors. Furthermore, in diseases that involve plasma cells such as multiple myeloma, panobinostat inhibits HDAC6 (a key enzyme in the elimination of pathologically hypersecreted monoclonal immunoglobulins) leading to cell death.

About BHQ880

BHQ880 is a first-in-class, fully human, anti-dickkopf-1 (DKK-1) neutralizing antibody. By inhibiting the DDK-1 antibody, BHQ880 promotes activity of osteoblasts, cells that form bones.

About INCB18424

INCB18424 (also known as INCB018424) is a Janus kinase (JAK) inhibitor. This oral targeted therapy is now in Phase III clinical trials for the treatment of myelofibrosis, a life-threatening neoplastic condition with no effective medical treatment that is characterized by varying degrees of bone marrow failure, splenomegaly (enlarged spleen) and debilitating symptoms. INCB18424 has the potential of becoming a first-in-class therapeutic agent for the treatment of this and other hematologic diseases.

About Zometa

ZOMETA is indicated for the treatment of hypercalcemia of malignancy (HCM) and patients with multiple myeloma and documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. Prostate cancer should have progressed after treatment with at least one hormonal therapy. Safe and efficacious use of ZOMETA has not been established for use in hyperparathyroidism or non-tumor-related hypercalcemia.

Zometa important safety information

ZOMETA is contraindicated in patients with hypersensitivity to zoledronic acid or any components of ZOMETA. Hypersensitivity reactions, including rare cases of urticaria and angioedema, and very rare cases of anaphylactic reaction/shock, have been reported. Patients being treated with ZOMETA should not be treated with Reclast as they contain the same active ingredient.

Patients with HCM must be adequately rehy
'/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... PHILADELPHIA , Nov. 26, 2014  Cohen, ... on behalf of investors who purchased Nymox Pharmaceutical ... ) during the period from January 31, 2011 ... concerns whether Nymox and certain of its officers ... information in violation of Sections 10(b) and 20(a) ...
(Date:11/26/2014)... Nov. 26, 2014   Regulus Therapeutics Inc . ... the discovery and development of innovative medicines targeting microRNAs, ... President and CEO of Regulus, will present a company ... Healthcare Conference at the New York Palace Hotel on ... presentation will be webcast at the time of the ...
(Date:11/26/2014)... , November 26, 2014 Investor-Edge ... VVUS ), Horizon Pharma PLC (NASDAQ: ... and Johnson (NYSE: JNJ ), and Theravance Inc. ... companies can be accessed at: http://investor-edge.com/register . ... 4,758.25, up 0.07%, the Dow Jones Industrial Average edged 0.02% ...
Breaking Medicine Technology:Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
... Jayex – http://www.jayex.com , the healthcare ... of Med-Extranet ; its online healthcare ... online access to educational videos, digital posters and public ... waiting room screens . Med-Extranet is ...
... FRANCISCO, Jan. 19, 2011 Jennerex, Inc. (San ... development of first-in-class, targeted oncolytic products for cancer, ... the newly-created position of vice president, regulatory affairs. ... regulatory strategies and managing all aspects of regulatory ...
Cached Medicine Technology:Digital Display System Specialist Jayex Launches Med-Extranet Online Media Library 2Digital Display System Specialist Jayex Launches Med-Extranet Online Media Library 3Jennerex Names Ursula Fritsch, PharmD, as Vice President, Regulatory Affairs 2
(Date:11/28/2014)... Miami's Plastic Surgery of the Face recently introduced ... Jeffrey Epstein is excited to offer patients the ... the site is uniquely designed for easing viewing on ... of all prospective rhinoplasty patients research upcoming procedures online. ... with smartphones, tablets, and laptops, as well as the ...
(Date:11/28/2014)... Minneapolis, Minnesota (PRWEB) November 28, 2014 ... one of the few insurance marketing organizations in ... the income and asset protection marketplace. Secura Consultants ... in partnership with Principal Financial Group, a leading ... with multiple ownership interests. With the ownership interest ...
(Date:11/28/2014)... THURSDAY, Nov. 27, 2014 (HealthDay News) -- Planning on ... from chronic heartburn -- clinically known as gastroesophageal reflux disease ... Dr. Jordan Josephson, an ear, nose and throat specialist ... these tips to help manage GERD on Thanksgiving: ... have at least two small meals throughout the day. It,s ...
(Date:11/28/2014)... November 28, 2014 PreDiabetes ... and treatment, helped employees learn their risk for ... blood screening at a local school in partnership ... Work initiative. , As the Presenting Sponsor ... , PreDiabetes Centers is co-hosting diabetes-prevention presentations at ...
(Date:11/28/2014)... 28, 2014 Mabel’s Labels , ... lose® and an award-winning company established by four moms, ... Esp, and Tricia Mumby have been honored with a ... with the PROFIT Award for Excellence in Entrepreneurship. , ... and Tricia Mumby) accepted the award on behalf of ...
Breaking Medicine News(10 mins):Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Secura Consultants Offers Complimentary Buy-Sell Agreement Reviews 2Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:PreDiabetes Centers Offers Workplace Diabetes Screening at Local School 2Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 2Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 3
... , , CHICAGO, ... Clinical Lab Expo in Chicago, Abbott (NYSE: ABT ) ... c4000(R) clinical chemistry analyzer which performs diagnostic tests that monitor general ... function. , , The new ...
... when employer-based coverage is not an option, survey finds, , ... United States who try to buy an individual health insurance ... because the premiums are just too expensive, according to a ... private foundation that supports independent research on health policy reform, ...
... ... serve residents, families , ... Wausau, Wisc. (Vocus) July 21, 2009 -- My InnerView, the leading provider of ... announced the creation of the My SeniorCare Edvantage Program, an online health management certificate ...
... , LAWRENCE, Mass. , July 21 ... leading manufacturer of innovative dialysis products, today announced that its ... distribution agreement with Fenwal, Inc. of Lake Zurich, Ill. ... medical technology company focused on improving blood collection, separation, safety ...
... Innovative child welfare practices from across the country offer hope ... , SEATTLE, July 21 All across America, child ... These changes are improving the lives of children in foster care as ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20070116/CASEYFAMILYLOGO ...
... , LA JOLLA, Calif., July 21 Kashi ... Dark Mocha Almond Chewy Granola Bar as the latest addition to the ... granola bar combines crunchy roasted almonds with rich dark chocolate and espresso for ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090331/LA91619LOGO ) , , "At Kashi, ...
Cached Medicine News:Health News:Abbott Launches New Instrument to Complete Family of ARCHITECT Immunochemistry Analyzers 2Health News:Abbott Launches New Instrument to Complete Family of ARCHITECT Immunochemistry Analyzers 3Health News:Abbott Launches New Instrument to Complete Family of ARCHITECT Immunochemistry Analyzers 4Health News:Millions in U.S. Can't Afford Health Insurance 2Health News:My InnerView and UW-Eau Claire Announce New Online Health Management Certificate Program for Senior Care Professionals 2Health News:My InnerView and UW-Eau Claire Announce New Online Health Management Certificate Program for Senior Care Professionals 3Health News:NxStage(R) Announces Extension of Medisystems Needle Supply and Distribution Agreement 2Health News:New Report Sets a Course for Improving Foster Care Systems 2Health News:New Report Sets a Course for Improving Foster Care Systems 3Health News:Kashi Company Introduces TLC(R) Dark Mocha Almond Chewy Bar 2
... The BiliChek measures total serum bilirubin ... no risk of infection compared to the ... Using light, BiliChek tests bilirubin levels without ... Only the replaceable plastic tip touches the ...
... 3900 Multi-Sample Osmometer is designed to ... to high volumes of samples. By ... technology for an accurate determination of ... throughput, the Advanced Instruments Model 3900 ...
... SSO typing technique utilises a generic PCR ... specific target region of an HLA locus. ... resulting amplicon to an array of Sequence ... membrane. The immobilisation of these probes is ...
... only a 20L sample size, which provides accurate ... convenience, the fully accessible probe design is easy ... only your most reliable option, it's the easiest ... a disposable sample tube, then place the tube ...
Medicine Products: